Markedsundersøgelse af Vagus nervestimulator

The Region of Southern Denmark is assisting The Danish Healthcare Quality Institute (DHQI) in conducting a market consultation about the existence of any CE marked technologies for the treatment of cluster headache. This is the case because DHQI is conducting an assessment of non-invasive vagus nerve stimulation (nVNS) technologies for …

CPV: 33158000 Aparatura do terapii elektrycznej, elektromagnetycznej i mechanicznej, 33158210 Stymulatory
Miejsce wykonania:
Markedsundersøgelse af Vagus nervestimulator
Miejsce udzielenia zamówienia:
Region Syddanmark
Numer nagrody:
1240

1. Køber

1.1 Køber

Officielt navn : Region Syddanmark
Køberens retlige status : Regional myndighed
Den ordregivende myndigheds aktivitet : Sundhed

2. Procedure

2.1 Procedure

Titel : Markedsundersøgelse af Vagus nervestimulator
Beskrivelse : The Region of Southern Denmark is assisting The Danish Healthcare Quality Institute (DHQI) in conducting a market consultation about the existence of any CE marked technologies for the treatment of cluster headache. This is the case because DHQI is conducting an assessment of non-invasive vagus nerve stimulation (nVNS) technologies for the treatment of cluster headache. The overall purpose of the DHQI is to assess new or existing health technologies to ensure most value for money in the delivery of treatments in the Danish healthcare system. A horizon scanning of international HTA-organizations revealed a single technology assessment from the Norwegian Institute of Public Health (NIPH) of transcutaneous non-invasive vagus nerve stimulation (gammaCore) for the treatment of cluster headache. gammaCore is a Class IIa therapeutic medical device. The treatment modality delivered by gammaCore is non-invasive vagus nerve stimulation, nVNS, (also: transcutaneous vagus nerve stimulation, tVNS). As part of the evaluation, the DHQI needs to know if other companies provide this, or a similar CE marked technology. With a similar technology, we mean a technology that delivers nVNS to treat cluster headache. We do not mean implantable nerve stimulation technologies or technologies that stimulates other nerves than the vagus nerve for the treatment of cluster headache. Please contact procurement officer Kent Melgaard Nielsen, kent.melgaard.nielsen@rsyd.dk in case your company provides the abovementioned CE marked technology. You will in return be asked to provide documentation for your technology to be included in the DHQI evaluation. We will appreciate your reply on 17th of February 2025 at the latest.
Intern ID : 1240

2.1.1 Formål

Kontraktens hovedformål : Varer
Primær klassifikation ( cpv ): 33158000 Elektrisk, elektromagnetisk og mekanisk terapi
Supplerende klassifikation ( cpv ): 33158210 Stimulator

2.1.2 Udførelsessted

Hvor som helst

2.1.4 Generelle oplysninger

Retsgrundlag :
Direktiv 2014/24/EU

8. Organisationer

8.1 ORG-0001

Officielt navn : Region Syddanmark
Registreringsnummer : 29190909
Postadresse : Damhaven 12
By : Vejle
Postnummer : 7100
Landsdel (NUTS) : Sydjylland ( DK032 )
Land : Danmark
Enhed : Kent Nielsen
Telefon : +45 99440372
Denne organisations roller :
Køber

8.1 ORG-0002

Officielt navn : Mercell Holding ASA
Registreringsnummer : 980921565
Postadresse : Askekroken 11
By : Oslo
Postnummer : 0277
Landsdel (NUTS) : Oslo ( NO081 )
Land : Norge
Enhed : eSender
Telefon : +47 21018800
Fax : +47 21018801
Internetadresse : http://mercell.com/
Denne organisations roller :
TED eSender
Oplysninger om bekendtgørelsen
Bekendtgørelsens ID : 7e388325-c161-4992-b75e-f4d2dd478845 - 01
Formulartype : Planlægning
Bekendtgørelsestype : Bekendtgørelse om offentliggørelse af en forhåndsmeddelelse eller en vejledende periodisk bekendtgørelse i en køberprofil
Afsendelsesdato for bekendtgørelsen : 03/02/2025 12:38 +00:00
Dato for afsendelse af bekendtgørelsen (eSender) : 03/02/2025 14:00 +00:00
Bekendtgørelsens officielle sprog : dansk
Bekendtgørelsesnummer : 00080500-2025
EUT-S-nummer : 25/2025
Offentliggørelsesdato : 05/02/2025